Project ECHO: Recognition and Care of Women with Bleeding Disorders
Session 2: Testing for Bleeding Disorders in OB/GYN Care
Our second webinar in a four-part series for OB/GYNs will look at the common labs ordered for patients with Heavy Menstrual Bleeding (HMB) and how to interpret the results. What additional testing can be done if the index of suspicion continues to be raised by the preliminary results? While this presentation is open to the public, the content is intended for OB/GYNs and will provide one CME credit for physicians, PAs, and nurses.
Host/Moderator: Patricia Huguelet, MD
Presenter: Maureen Baldwin, MD
Target Audience: OB/GYN
Session Objectives
- Identify resources to screen and monitor gynecologic and obstetric bleeding symptoms.
- Identify the standard laboratory evaluation to test for bleeding disorders.
- Identify pitfalls of testing and referral considerations.
- Recognize next steps in care if a bleeding disorder is suspected.
| Time | Presentation | Presenters |
| 12:00–12:02 PM ET | Welcome, Introductions, and Housekeeping | Patricia Huguelet, MD |
| 12:02–12:22 PM ET | Didactic Presentation: Testing for Bleeding Disorders in OB/GYN Care | Maureen Baldwin, MD |
| 12:22–12:27 PM ET | Question and Answer | Maureen Baldwin, MD |
| 12:27–12:42 PM ET | Case Presentation | Patricia Huguelet, MD |
| 12:42–12:47 PM ET | Clarifying Questions | Patricia Huguelet, MD |
| 12:47–12:57 PM ET | Recommendations | Maureen Baldwin, MD |
| 12:57–12:59 PM ET | Wrap-Up | Patricia Huguelet, MD |
| 12:59–1:00 PM ET | Closing Remarks | Patricia Huguelet, MD |
Reminders
| PHI | All patient information will be de-identified during the ECHO session. |
| Recording | This session may be audio and video recorded. Your participation confirms your consent to this recording. |
| Continuing Medical Education Credit | 1 Hour |


In support of improving patient care, this activity has been planned and implemented by the Hemophilia Federation of America and Project ECHO. Project ECHO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Designation Statement
Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Designation Statement
Project ECHO designates this live activity for a maximum of 1.0 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation.
AAPA Credit Designation Statement—Live


Project ECHO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Disclosure Statement
Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.
None of the planners and presenters for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Planners: Jacey Gonzalez, BA; Skye Peltier, MPH, PA-C; Janet Chupka, RN, BSN; and Emily Roush-Bobolz, BA
The following planners/presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company.
| Name | Nature of Relationship | Name of Ineligible Company |
| Patricia Huguelet, MD | Speaker Speaker | Bayer Pharmaceuticals Hemophilia Federation of America |
| Stormy Johnson | Speaker Music project | Medexus Pharmaceutical Sanofi |
| Kristina Haley, DO, MCR | Consultant Researcher | Regence/Cambia Spark Therapeutics |
| Maureen Baldwin, DO | Consultant and Advisor | BioMarin Pharmaceuticals |
All of the relevant financial relationships listed for these individuals have been mitigated.
This project is supported by cooperative agreement DD000008 from the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of an annual financial assistance award totaling $320,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.